Lung Cancer Section
-
Lung cancer survivorship: Life beyond diagnosis, treatment, and rechecks
It is no longer enough to “survive” lung cancer; our responsibility as pulmonologists is to help survivors persevere beyond it.
-
EBUS nodal staging in early-stage non-small cell lung cancer
EBUS-TBNA disrupted the field of bronchoscopy by offering a minimally invasive, real-time imaging approach to biopsy, but recent data have emerged that show routine use of EBUS may warrant scrutiny.
-
Artificial intelligence in lung cancer management
As artificial intelligence continues to integrate into clinical practice, the future of lung cancer management is shifting toward precision-driven, data-informed strategies and risk prediction models.
-
Atypical pulmonary cysts: Why to care
Since the American College of Radiology (ACR) updated its Lung CT Screening Reporting & Data System (Lung-RADS) to include atypical pulmonary cysts in 2022, there has been little discussion among chest physicians regarding the significance of pulmonary cysts and why these changes were made. Lung-RADS 2022 defined atypical pulmonary cysts as single, unilocular cysts with…
-
Nurturing health equity in smoking cessation care
Lung cancer stands as the leading cause of cancer-related deaths globally, with its prevalence casting a long and challenging shadow. The most important risk factor for lung cancer is tobacco use, a relationship strongly substantiated by data. The impact of smoking cessation to reduce lung cancer incidence is underscored by the US Preventive Services Task…
